ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety and Immunogenicity of Replication-Competent Adenovirus 4-vectored Vaccine for Avian Influenza H5N1

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01006798
Recruitment Status : Completed
First Posted : November 3, 2009
Last Update Posted : July 1, 2013
Sponsor:
Information provided by (Responsible Party):
PaxVax, Inc.